This study aimed to investigate the effects of different doses of systemic melatonin application on new bone formation during mandibular distraction osteogenesis (DO) in rats. Mandibular DO was performed on 30 adult female Sprague-Dawley rats, which were randomly divided into three groups: control group (CNT), melatonin dose 1 (MLT-D1), and melatonin dose 2 (MLT-D2). A five-day latent waiting period and a ten-day distraction phase followed the surgery. After the surgery, rats from the MLT-D1 and MLT-D2 groups received 25 and 50 mg/kg melatonin, respectively, at 7, 14, 21, 28, and 35 days. The animals were euthanised 28 days after distraction, i.e. at 43 days after surgery. Histological and histomorphometric analyses revealed that the distracted bone area was completely filled with new bone formation in all three groups. The MLT-D2 group exhibited the most new bone formation, followed by MLT-D1 and CNT. The melatonin groups had more osteoclasts than the CNT (p < 0.05). The number of osteoblasts was higher in the melatonin groups than in the CNT group, and the MLT-D2 had more osteoclasts than the MLT-D1 group (p < 0.05). Finally, the osteopontin (OPN) and vascular endothelial growth factor (VEGF) levels were higher in the melatonin groups than in the CNT group, and the MLT-D2 had higher OPN and VEGF levels than the MLT-D1 (p < 0.05). This study suggests that systemic melatonin application could increase new bone formation in DO.
30 January 2026 in Maxillofacial Plastic and Reconstructive Surgery
Background: Although piezosurgery has become a common technique in maxillofacial procedures—including third molar extractions—its advantages over conventional rotary instruments regarding postoperative recovery are still debated. Therefore, this randomized clinical trial aimed to evaluate and compare postoperative complications following the removal of impacted mandibular third molars using either piezosurgery or conventional rotary instruments. Methods: This randomized controlled clinical trial included a total of 50 participants who were randomly allocated into two groups: the piezosurgery group and the conventional surgery group. Postoperative outcomes were assessed in patients who underwent surgical extraction of impacted mandibular third molars using one of these two methods. Pain levels were recorded daily using a Visual Analog Scale (VAS), whereas swelling, mouth opening, and oral health–related quality of life were evaluated before surgery and again on postoperative days two and seven. Results: The piezosurgery technique resulted in a faster reduction of postoperative swelling on the second day; however, by the seventh day, no statistically significant differences were found between the two surgical techniques with respect to postoperative swelling. Similarly, there were no significant variations between the piezosurgery and conventional methods in terms of postoperative pain, mouth opening, or oral health–related quality of life throughout the observation period. Conclusion: Piezosurgery appears to offer a potential advantage; however, apart from reducing swelling, it does not demonstrate any significant superiority in terms of mouth opening, pain, or quality of life. Further standardized, large-scale randomized controlled studies are needed to obtain stronger evidence regarding the efficacy of both techniques.
Background: Early implant stability is a relevant surrogate during the transition from mechanical primary stability to biologically mediated secondary stability. Cold plasma activation may improve titanium surface readiness, but direct clinical comparisons remain limited. Methods: This prospective, single-center, randomized, within-patient controlled trial compared untreated control implants with three pre-insertion plasma protocols: vacuum plasma, argon jet plasma, and cold atmospheric plasma. Eleven patients received 44 implants. One patient/four implants was excluded for insufficient primary stability. The final analysis included 40 implants in 10 patients, each contributing one implant per group. Implant sites were not anatomically mirrored. Plasma was applied for 60 s before placement. Implant stability quotient (ISQ) was recorded at baseline and at 14, 28, and 56 days. A nested linear mixed-effects model was used for statistical inference. Results: All analyzed implants remained in situ throughout follow-up, and no adverse events were recorded. Baseline ISQ values were comparable across groups (70.6–70.9), without establishing anatomical equivalence. Control implants showed a transient ISQ decrease at day 28, whereas plasma-treated implants showed increasing ISQ values. The group-by-time interaction was significant (likelihood-ratio chi-square(9) = 188.73, p < 0.001). At day 56, model-based mean differences versus control were + 10.0 ISQ units for vacuum plasma, + 8.9 for argon jet plasma, and + 8.3 for cold atmospheric plasma (all p < 0.001). Sensitivity analyses preserved the association direction. Conclusions: Cold plasma activation was associated with a more favorable early ISQ trajectory than untreated implants during the first 8 weeks. Given the small, retrospectively registered, site-heterogeneous, ISQ-based design, larger prospectively registered, site-standardized trials are warranted. Trial registration: Retrospectively registered at ClinicalTrials.gov, NCT07348770. First submitted: 11 December 2025; first posted: 16 January 2026; latest update posted: 11 May 2026.
Background and Objectives: This study aims to assess the bone implant osseointegration after the healing process of machined, reabsorbable blast material (RBM) and sandblasted and large acid grid (SLA) surface titanium implants placed simultaneously using graft material in rat tibias. Materials and Methods: The study involved 30 Sprague Dawley rats that were divided into three groups: machined surfaced (MS) (n = 10), resorbable blast material (RBM) (n = 10), and sandblasted and large acid grid (SLA) surfaced (n = 10). The titanium implants were inserted into the bone sockets along with the graft, and the rats were euthanized after a 4-week experimental period. The implants and the bone tissue surrounding them were extracted for reverse torque analysis (Newton’s). Results: The biomechanical bone implant contact rate was greater in SLA-surfaced implants than in RBM and machined surface implants (P<0.05). Conclusions: The application of graft material may be more effective in implants with SLA and RBM surfaces when used locally, as per the biomechanical parameters.
To evaluate whether cold atmospheric plasma (CAP) and argon-assisted cold atmospheric plasma (CAP-Ar) treatment of silk and polytetrafluoroethylene (PTFE) sutures influences postoperative sequelae and oral health-related quality of life after mandibular third molar surgery. In this single-center randomized pilot clinical trial, 60 adults undergoing impacted mandibular third molar surgery were allocated to six groups: silk, silk-CAP, silk-CAP-Ar, PTFE, PTFE-CAP, and PTFE-CAP-Ar (n = 10 per group). CAP or CAP-Ar was applied to 5-cm segments of the assigned suture material for 60 s immediately before wound closure. Postoperative pain was assessed using a visual analog scale, facial swelling by three-dimensional facial scanning, mouth opening clinically, and oral health-related quality of life using the OHIP-14 questionnaire at predefined postoperative time points. Sixty participants were included in the analysis. No statistically significant between-group differences were observed for postoperative pain, facial swelling, mouth opening, or OHIP-14 scores at any evaluated time point (p > 0.05). Under the conditions of this pilot trial, neither suture material (silk vs. PTFE) nor plasma treatment (CAP or CAP-Ar) significantly improved postoperative sequelae or oral health-related quality of life after mandibular third molar surgery. These preliminary findings should be confirmed in larger definitive randomized clinical trials. In this pilot sample, plasma treatment of silk or PTFE sutures does not appear to provide a measurable short-term clinical benefit in routine mandibular third molar surgery.
Objectives This investigation aimed to examine the effect of oral systemic strontium ranelate on the osseointegration of titanium implants placed in rat tibias without primary stabilization. It was hypothesized that strontium ranelate, which has functions similar to those of bisphosphonates (whose effects on bone tissue are known), may increase bone-implant connection (BIC) without primary stabilization. Materials and Methods The rats were divided into four coequal groups with 11 rats in each group: a primary stabilization control group (PS+) (n = 11), a strontium ranelate-administered (625 mg/kg) group with primary stabilization (PS+STR) (n = 11), a control group without primary stabilization (PS-) (n=11), and a strontium ranelate administered (625 mg/kg) group without primary stabilization (PS+STR) (n = 11). A 625 mg/kg dose of strontium ranelate was administered daily by means of oral gavage to the experimental groups; no supplemental therapy was provided to the other groups throughout the experiment. At the end of the fourteen-day experimental period, the BIC values of the implants were biomechanically measured using reverse torque analysis. Results Lower BIC values were detected in the PS-groups than in the PS+ groups (P < 0.05). The BIC values were higher in the PS(+)-strontium-administered group than in the PS(+) group (P < 0.05). Although strontium administration without primary stability resulted in a numerical increase in BIC values, this difference was not statistically significant (P > 0.05). Conclusion This study shows that primary stabilization is an important factor for BIC, and it can be concluded that strontium ranelate can increase BIC with primary stabilization.